WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1983004260) HUMAN LEUKOCYTE PEPSIN-LIKE ENZYME, AND A THERAPEUTIC AGENT CONTAINING SAID ENZYME AS EFFECTIVE INGREDIENT FOR TREATING ALLERGIC DISORDER, IMMUNE COMPLEX DISEASE, AND TUMOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1983/004260    International Application No.:    PCT/JP1982/000213
Publication Date: 08.12.1983 International Filing Date: 31.05.1982
IPC:
A61K 9/127 (2006.01), C12N 15/00 (2006.01), C12N 9/64 (2006.01), A61K 38/00 (2006.01)
Applicants: MOCHIDA PHARMACEUTICAL CO., LTD. [JP/JP]; 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160 (JP) (For All Designated States Except US).
OHNISHI, Haruo [JP/JP]; (JP) (For US Only).
KOSUZUME, Hiroshi [JP/JP]; (JP) (For US Only).
SUZUKI, Yasuo [JP/JP]; (JP) (For US Only).
MOCHIDA, Ei [JP/JP]; (JP) (For US Only)
Inventors: OHNISHI, Haruo; (JP).
KOSUZUME, Hiroshi; (JP).
SUZUKI, Yasuo; (JP).
MOCHIDA, Ei; (JP)
Agent: HANABUSA, Masami @; Hanabusa Patent Office, Shufunotomo Bldg., 6, Kandasurugadai 1-chome, Chiyoda-ku, Tokyo 101 (JP)
Priority Data:
Title (EN) HUMAN LEUKOCYTE PEPSIN-LIKE ENZYME, AND A THERAPEUTIC AGENT CONTAINING SAID ENZYME AS EFFECTIVE INGREDIENT FOR TREATING ALLERGIC DISORDER, IMMUNE COMPLEX DISEASE, AND TUMOR
(FR) ENZYME ANALOGUE DE LA PEPSINE DE LEUCOCYTE HUMAIN ET AGENT THERAPEUTIQUE CONTENANT CETTE ENZYME EN TANT QU'INGREDIENT EFFECTIF POUR LE TRAITEMENT DE TROUBLES ALLERGIQUES, DE MALADIES AUTO-IMMUNITAIRES ET DE TUMEURS
Abstract: front page image
(EN)Since the human leukocyte pepsin-like enzyme is of human origin, the therapeuting agent containing the same as effective ingredient shows an extremely weak side effect of inducing anaphylactic shock due to antigenicity, thus being used with a very high safety.
(FR)Etant donné que l'enzyme analogue de la pepsine de leucocyte humain est d'origine humaine, l'agent thérapeutique la contenant en tant qu'ingrédient effectif présente des effets secondaires extrêmement faibles en ce qui concerne le choc anaphylactique provoqué par l'antigénicité et peut, par conséquent, être utilisé avec un degré élevé de sécurité.
Designated States: AU, CH, DE, GB, JP, NL, SE, US.
European Patent Office (FR).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)